Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine

Background: Methamphetamine use disorder (MUD) is a growing health concern with no FDA-approved treatment. The present series of studies build upon our previous work developing an anti-methamphetamine (MA) vaccine for MUD. We determined the effects of a formulation that included tetanus-toxoid (TT)...

Full description

Bibliographic Details
Main Authors: Colin N. Haile, Kurt J. Varner, Xia Huijing, Reetakshi Arora, Frank M. Orson, Thomas R. Kosten, Therese A. Kosten
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/9/1508
_version_ 1797481573818302464
author Colin N. Haile
Kurt J. Varner
Xia Huijing
Reetakshi Arora
Frank M. Orson
Thomas R. Kosten
Therese A. Kosten
author_facet Colin N. Haile
Kurt J. Varner
Xia Huijing
Reetakshi Arora
Frank M. Orson
Thomas R. Kosten
Therese A. Kosten
author_sort Colin N. Haile
collection DOAJ
description Background: Methamphetamine use disorder (MUD) is a growing health concern with no FDA-approved treatment. The present series of studies build upon our previous work developing an anti-methamphetamine (MA) vaccine for MUD. We determined the effects of a formulation that included tetanus-toxoid (TT) conjugated to succinyl-methamphetamine (TT-SMA) adsorbed onto aluminum hydroxide (alum) in combination with the novel Toll-Like Receptor-5 agonist, entolimod. Methods: Mice were vaccinated (0, 3, 6 weeks) with TT-SMA+alum and various doses of entolimod to determine an optimal dose for enhancing immunogenicity against MA. Functional effects were then assessed using MA-induced locomotor activation in mice. Experiments using passive immunization of antibodies generated by the vaccine tested its ability to attenuate MA-induced cardiovascular effects and alter the reinforcing effects of MA in an MA-induced reinstatement of a drug seeking model of relapse in male and female rats. Results: Antibody levels peaked at 10 weeks following vaccination with TT-SMA+alum combined with entolimod (1, 3 and 10 <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mi mathvariant="sans-serif">μ</mi></semantics></math></inline-formula>g). MA-induced locomotor activation was significantly attenuated in vaccinated vs. unvaccinated mice and antibody levels significantly correlated with ambulation levels. Passive immunization decreased mean arterial pressure following MA dosing in rats of both sexes but did not alter heart rate. Passive immunization also attenuated the ability of MA to reinstate extinguished drug-seeking behavior in male and female rats. Results support further development of this vaccine for relapse prevention for individuals with MUD.
first_indexed 2024-03-09T22:16:33Z
format Article
id doaj.art-b78660c9227a43e9b51847c33f5f5a46
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T22:16:33Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-b78660c9227a43e9b51847c33f5f5a462023-11-23T19:22:20ZengMDPI AGVaccines2076-393X2022-09-01109150810.3390/vaccines10091508Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of MethamphetamineColin N. Haile0Kurt J. Varner1Xia Huijing2Reetakshi Arora3Frank M. Orson4Thomas R. Kosten5Therese A. Kosten6Department of Psychology/TIMES, University of Houston, Houston, TX 77204, USADepartment of Pharmacology and Experimental Therapeutics and the Cardiovascular Center of Excellence, LSUHSC, New Orleans, LA 70112, USADepartment of Pharmacology and Experimental Therapeutics and the Cardiovascular Center of Excellence, LSUHSC, New Orleans, LA 70112, USAThe Michael E DeBakey Veteran’s Affairs Medical Center, Houston, TX 77030, USAThe Michael E DeBakey Veteran’s Affairs Medical Center, Houston, TX 77030, USAThe Michael E DeBakey Veteran’s Affairs Medical Center, Houston, TX 77030, USADepartment of Psychology/TIMES, University of Houston, Houston, TX 77204, USABackground: Methamphetamine use disorder (MUD) is a growing health concern with no FDA-approved treatment. The present series of studies build upon our previous work developing an anti-methamphetamine (MA) vaccine for MUD. We determined the effects of a formulation that included tetanus-toxoid (TT) conjugated to succinyl-methamphetamine (TT-SMA) adsorbed onto aluminum hydroxide (alum) in combination with the novel Toll-Like Receptor-5 agonist, entolimod. Methods: Mice were vaccinated (0, 3, 6 weeks) with TT-SMA+alum and various doses of entolimod to determine an optimal dose for enhancing immunogenicity against MA. Functional effects were then assessed using MA-induced locomotor activation in mice. Experiments using passive immunization of antibodies generated by the vaccine tested its ability to attenuate MA-induced cardiovascular effects and alter the reinforcing effects of MA in an MA-induced reinstatement of a drug seeking model of relapse in male and female rats. Results: Antibody levels peaked at 10 weeks following vaccination with TT-SMA+alum combined with entolimod (1, 3 and 10 <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mi mathvariant="sans-serif">μ</mi></semantics></math></inline-formula>g). MA-induced locomotor activation was significantly attenuated in vaccinated vs. unvaccinated mice and antibody levels significantly correlated with ambulation levels. Passive immunization decreased mean arterial pressure following MA dosing in rats of both sexes but did not alter heart rate. Passive immunization also attenuated the ability of MA to reinstate extinguished drug-seeking behavior in male and female rats. Results support further development of this vaccine for relapse prevention for individuals with MUD.https://www.mdpi.com/2076-393X/10/9/1508conjugate vaccineentolimodmethamphetamine use disorderlocomotor activitydrug reinstatementmedication development
spellingShingle Colin N. Haile
Kurt J. Varner
Xia Huijing
Reetakshi Arora
Frank M. Orson
Thomas R. Kosten
Therese A. Kosten
Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine
Vaccines
conjugate vaccine
entolimod
methamphetamine use disorder
locomotor activity
drug reinstatement
medication development
title Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine
title_full Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine
title_fullStr Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine
title_full_unstemmed Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine
title_short Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine
title_sort active and passive immunization with an anti methamphetamine vaccine attenuates the behavioral and cardiovascular effects of methamphetamine
topic conjugate vaccine
entolimod
methamphetamine use disorder
locomotor activity
drug reinstatement
medication development
url https://www.mdpi.com/2076-393X/10/9/1508
work_keys_str_mv AT colinnhaile activeandpassiveimmunizationwithanantimethamphetaminevaccineattenuatesthebehavioralandcardiovasculareffectsofmethamphetamine
AT kurtjvarner activeandpassiveimmunizationwithanantimethamphetaminevaccineattenuatesthebehavioralandcardiovasculareffectsofmethamphetamine
AT xiahuijing activeandpassiveimmunizationwithanantimethamphetaminevaccineattenuatesthebehavioralandcardiovasculareffectsofmethamphetamine
AT reetakshiarora activeandpassiveimmunizationwithanantimethamphetaminevaccineattenuatesthebehavioralandcardiovasculareffectsofmethamphetamine
AT frankmorson activeandpassiveimmunizationwithanantimethamphetaminevaccineattenuatesthebehavioralandcardiovasculareffectsofmethamphetamine
AT thomasrkosten activeandpassiveimmunizationwithanantimethamphetaminevaccineattenuatesthebehavioralandcardiovasculareffectsofmethamphetamine
AT thereseakosten activeandpassiveimmunizationwithanantimethamphetaminevaccineattenuatesthebehavioralandcardiovasculareffectsofmethamphetamine